Pharmaterials Ltd The Queen's Awards for Enterprise 2008
Home
Company Locations
Careers
Initiate a Project
Contact Us
Request A Brochure
Search Our Site
Home | COMPANY    |     POLYMORPHS/SALTS/CO-CRYSTALS    |     FORMULATION DEVELOPMENT    |     CONSULTANCY    |     GMP MANUFACTURE    |     PHYS PROPS    |     INHALATION SERVICES    |    
Formulation Development
Preclinical Formulation Clinical Formulation Solid Oral Dosage Amorphous Solid Dispersions MacroSOLV Formulation Screening Inhaled / Respiratory Drug Delivery: Inhalation product development First time in human fast Analytical Development Excipient compatibility testing Drug Delivery Licensing Quality by Design in Formulation Development

Rapid reliable excipient compatibility testing

The assessment of stability (of actives, excipients and/or formulated products) is an important, and often time-consuming part of pharmaceutical product development.

During early preclinical development of formulations, it is often required to test for compatibility between the active ingredient and a variety of chosen excipients. It is often advantageous to speed up the formulation process using rapid methods rather than conventional stability testing.

Using INNOVATIVE IN HOUSE METHODS sophisticated high sensitivity instruments, we can screen dozens of excipients and actives in parallel, with a typical full screening program lasting just a few days!  No simple DSC methods, improved method for rapid results and differentiation of physical and chemical effects.

Such supporting studies can dramatically reduce the time required for development by rapidly giving a go/no go decision on excipient choice to be used in the formulation.

  Home  |  Company  |  Polymorphs/Salts/Co-crystals  |  Formulation Development  |  Consultancy  |  GMP manufacture  |  Phys Props  |  Inhalation services  |  News  |  Site Map
© 2009 Pharmaterials Ltd, All rights reserved.       Site by : UKWebCo.com